RecruitingNot Applicable

Clinical Outcomes Following Primary Intracerebral Hemorrhage

China25,000 participantsStarted 2016-10-27

Plain-language summary

The investigators design an observational multi-center cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalized adult patients with primary intracerebral hemorrhage.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- We included adult patients who (1) admitted for primary ICH ; (2) underwent blood routine test (hemoglobin included) and CT scan as soon as they arrived at hospital; (3) were not treated with neurosurgical procedures. Exclusion Criteria: * We excluded patients who (1) had ICH secondary to known causes, including trauma, intracranial neoplasm and systemic diseases12, as well as anticoagulative agents; or had isolated intraventricular hemorrhage (IVH); (2) mRS \>2 before the current ICH episode (according to past medical records or description from guardians.

What they're measuring

All-cause death

Timeframe: 5 years after ICH

ICH recurrence

Timeframe: 5 years after ICH

3-month outcome

Timeframe: 3 months after ICH

Trial details

NCT IDNCT06548737

SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12-31

Contact for this trial

Feng Gao, Dr

+86-13588451471 2202012@zju.edu.cn

View on ClinicalTrials.gov More Stroke trials